Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - August 2013


CHI's Next Generation Dx Summit

20 Aug 2013 - 22 Aug 2013 - Washington, DC, USA



Bookmark and Share


From August 20-22, 2013 at the Hyatt Regency Washington on Capitol Hill, diagnostic professionals will have the opportunity to choose from 13 short courses and 7 concurrent tracks covering:

Point-of-Care Diagnostics

Cancer Molecular Markers to Guide Therapy

Molecular Diagnostics for Infectious Disease

Companion Diagnostics: From Biomarker Validation to Regulatory Approval

Commercialization of Molecular Diagnostics

Companion Diagnostics: Advancing Technologies and Winning Reimbursement

Molecular Profiling of Circulating Tumor Cells

This year's plenary keynote session will feature a discussion on perspectives on evaluating novel diagnostics for reimbursement.  The panel will be moderated by Andrew Fish of AdvaMedDx and will feature Elaine Jeter of Palmetto GBA, Aaron Bossler of University of Iowa Hospitals and Clinics/AMP Economic Affairs Committee, Dwight Denham of Beckman Coulter, and Lee Newcomer of United Healthcare.

Attendees will also hear presentations from Dr. William Dalton of H. Lee Moffitt Cancer Center & Research Institute, Dr. Sailesh Chutani of Mobisante, Pamela Swatkowski of Abbott Molecular, Dr. James Musser of The Methodist Hospital Research Institute, Dr. Susan Novak-Weekley of Southern California Permanente Medical Group, Dr. Jeffrey Ross of Foundation Medicine, Dr. Jack Lichy of VA Medical Center, Harry Glorikian of Scientia Advisors, and Dr. Randall Hayden of St. Jude Children's Research Hospital.

The Next Generation Dx Summit attracted over 600 attendees last year and is on track to continue growing this year.  

For complete details of this year's program and to register, visit www.NextGenerationDx.com.  



Further information
Scientific News
‘Smelling’ Prostate Cancer
A research team from the University of Liverpool and the University of the West of England (UWE Bristol) has reached an important milestone towards creating a urine diagnostic test for prostate cancer that could mean that invasive diagnostic procedures that men currently undergo eventually become a thing of the past.
Criminal Justice Alcohol Program Linked to Decreased Mortality
Institute has announced that in the criminal justice alcohol program deaths dropped by 4.2 percent over six years.
Charting Kidney Cancer Metabolism
Changes in cell metabolism are increasingly recognized as an important way tumors develop and progress, yet these changes are hard to measure and interpret. A new tool designed by MSK scientists allows users to identify metabolic changes in kidney cancer tumors that may one day be targets for therapy.
Individuals' Medical Histories Predicted by their Noncoding Genomes
Researchers have found that analyzing mutations in regions of the genome that control genes can predict medical conditions such as hypertension, narcolepsy and heart problems.
'Molecular Movie' Opens Door to New Cancer Treatments
An international team of scientists led by the University of Liverpool has produced a 'structural movie' revealing the step-by-step creation of an important naturally occurring chemical in the body that plays a role in some cancers.
Advancing Synthetic Biology
Living systems rely on a dizzying variety of chemical reactions essential to development and survival. Most of these involve a specialized class of protein molecules — the enzymes.
Preparing for Potential Zika Outbreaks
Experts at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) are developing tools to monitor the spread of the Zika virus and are conducting research to gather more solid data to better assess the risks associated with the infection.
What do Banana Peels and Human Skin Have in Common?
Human skin and banana peels have something in common: they produce the same enzyme when attacked. By studying fruit, researchers have come up with an accurate method for diagnosing the stages of this form of skin cancer.
Biomarker for Recurring HPV-Linked Oropharyngeal Cancers
A look-back analysis of HPV infection antibodies in patients treated for oropharyngeal (mouth and throat) cancers linked to HPV infection suggests at least one of the antibodies could be useful in identifying those at risk for a recurrence of the cancer, say scientists at the Johns Hopkins University.
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!